Lumos Pharma, Inc.
LUMO
Revenue
488.00k
▲323.00k▲195.76%
3 Months ChangeAssets
21.36M
▼-6.72M▼-23.94%
3 Months ChangeLiabilities
11.08M
▲441.00k▲4.15%
3 Months ChangeFree Cash Flow
-14.68M
▼-1.63M▼-12.51%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001140361-24-043979
2024-08-02
Form 10-Q
ID: 0001126234-24-000088
2024-08-01
Form 8-K
ID: 0001126234-24-000086
2024-06-05
Form 8-K
ID: 0001126234-24-000066
2024-05-15
Form 10-Q
ID: 0001126234-24-000062
2024-05-15
Form 8-K
ID: 0001126234-24-000059
2024-04-18
Form 8-K
ID: 0001126234-24-000052
2024-03-20
Form 8-K
ID: 0001126234-24-000027
2024-03-07
Form 8-K
ID: 0001126234-24-000024
2024-01-04
Form 8-K
ID: 0001126234-24-000002